HealthEquity (HQY)


Market Price (11/5/2026): $108.3 | Market Cap: $9.0 BilSector: Health Care | Industry: Managed Health Care

HealthEquity (HQY)


Market Price (11/5/2026): $108.3
Market Cap: $9.0 Bil
Sector: Health Care
Industry: Managed Health Care

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 26%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 36%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 32%

Low stock price volatility
Vol 12M is 36%

Megatrend and thematic drivers
Megatrends include Fintech & Digital Payments. Themes include Digital Payments, Online Banking & Lending, and Wealth Management Technology.

Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is -5.0%

Weak multi-year price returns
2Y Excs Rtn is -3.9%, 3Y Excs Rtn is -32%

Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 25x, P/EPrice/Earnings or Price/(Net Income) is 38x

Key risks
HQY key risks include [1] the high sensitivity of its custodial revenue to interest rate declines and [2] regulatory or healthcare policy changes that could undermine the market for its core HSA products.

0 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 26%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 36%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 32%
2 Low stock price volatility
Vol 12M is 36%
3 Megatrend and thematic drivers
Megatrends include Fintech & Digital Payments. Themes include Digital Payments, Online Banking & Lending, and Wealth Management Technology.
4 Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is -5.0%
5 Weak multi-year price returns
2Y Excs Rtn is -3.9%, 3Y Excs Rtn is -32%
6 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 25x, P/EPrice/Earnings or Price/(Net Income) is 38x
7 Key risks
HQY key risks include [1] the high sensitivity of its custodial revenue to interest rate declines and [2] regulatory or healthcare policy changes that could undermine the market for its core HSA products.

HQY in ETFs

Weight = HQY's share of each fund

VTI0.01%
ITOT0.01%
IWM0.28%
IJH0.25%
VB0.09%
IHF1.0%
IWO0.58%
NUSC0.50%
+17 more covered ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 11/4/2026

HealthEquity (HQY) stock has gained about 10% since 7/31/2026 because of the following key factors:

1. Strong Fiscal Q2 2027 Earnings Outperformance and Raised Guidance.

HealthEquity (whose fiscal year ends January 31) announced robust financial results for its fiscal Q2 2027 (ended July 31, 2026), surpassing Wall Street expectations. The company reported non-GAAP earnings of $1.24 per share, exceeding the Zacks Consensus Estimate of $1.19 per share and analysts' estimates of $1.15 per share. Additionally, revenue reached $350.7 million, surpassing forecasts of $349.22 million and marking an 8% year-over-year increase. This strong performance, which included a 10% increase in net income to $65.6 million and an 11% rise in Adjusted EBITDA to $167.0 million with a record 48% margin, prompted HealthEquity to raise its full-year fiscal 2027 guidance for both revenue and Adjusted EBITDA.

2. Significant Growth in Core HSA Business Metrics.

The company demonstrated strong underlying business growth during fiscal Q2 2027. Total Health Savings Account (HSA) assets expanded by 14% year-over-year to $37.9 billion. Furthermore, the number of new HSAs from sales surged by 24%, reflecting increasing demand for health savings solutions. Total HSA accounts grew by 8% year-over-year, reaching 10.7 million.

Show more
Updated on 11/4/2026

HealthEquity (HQY) stock has gained about 10% since 7/31/2026 because of the following key factors:

1. Strong Fiscal Q2 2027 Earnings Outperformance and Raised Guidance.

HealthEquity (whose fiscal year ends January 31) announced robust financial results for its fiscal Q2 2027 (ended July 31, 2026), surpassing Wall Street expectations. The company reported non-GAAP earnings of $1.24 per share, exceeding the Zacks Consensus Estimate of $1.19 per share and analysts' estimates of $1.15 per share. Additionally, revenue reached $350.7 million, surpassing forecasts of $349.22 million and marking an 8% year-over-year increase. This strong performance, which included a 10% increase in net income to $65.6 million and an 11% rise in Adjusted EBITDA to $167.0 million with a record 48% margin, prompted HealthEquity to raise its full-year fiscal 2027 guidance for both revenue and Adjusted EBITDA.

2. Significant Growth in Core HSA Business Metrics.

The company demonstrated strong underlying business growth during fiscal Q2 2027. Total Health Savings Account (HSA) assets expanded by 14% year-over-year to $37.9 billion. Furthermore, the number of new HSAs from sales surged by 24%, reflecting increasing demand for health savings solutions. Total HSA accounts grew by 8% year-over-year, reaching 10.7 million.

3. Positive Analyst Sentiment and Upgraded Price Targets.

Following the strong fiscal Q2 2027 results and increased guidance, several financial analysts reiterated "Buy" or "Strong Buy" ratings and increased their price targets for HealthEquity stock. For instance, BMO Capital Markets raised its price target from $105.00 to $125.00 on October 21, 2026. Barclays also increased its price target from $110 to $115 on September 18, 2026. S&P Global Ratings upgraded HealthEquity's rating to 'BB+' from 'BB', citing the company's expanding EBITDA base and favorable market conditions, while Raymond James reiterated a "Strong Buy" rating.

4. Favorable Macroeconomic and Industry Tailwinds.

HealthEquity continues to benefit from broader industry trends, including the increasing adoption of higher-deductible health plans and expanded HSA eligibility. These factors, driven in part by healthcare affordability pressures, contribute to a larger addressable market for the company's services and reinforce the durability of its business model.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 8.2% change in HQY stock from 7/31/2026 to 11/4/2026 was primarily driven by a 4.2% change in the company's P/E Multiple.
(LTM values as of)731202611042026Change
Stock Price ($)100.61108.848.2%
Change Contribution By: 
Total Revenues ($ Mil)1,3371,3621.9%
Net Income Margin (%)17.3%17.4%0.6%
P/E Multiple36.838.44.2%
Shares Outstanding (Mil)84831.2%
Cumulative Contribution8.2%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2026 to 11/4/2026
ReturnCorrelation
HQY8.2% 
Market (SPY)2.6%9.0%
Sector (XLV)16.7%37.9%

Fundamental Drivers

The 32.7% change in HQY stock from 4/30/2026 to 11/4/2026 was primarily driven by a 18.0% change in the company's P/E Multiple.
(LTM values as of)430202611042026Change
Stock Price ($)82.03108.8432.7%
Change Contribution By: 
Total Revenues ($ Mil)1,3131,3623.7%
Net Income Margin (%)16.4%17.4%6.0%
P/E Multiple32.538.418.0%
Shares Outstanding (Mil)85832.4%
Cumulative Contribution32.7%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 11/4/2026
ReturnCorrelation
HQY32.7% 
Market (SPY)7.0%-5.0%
Sector (XLV)30.5%37.2%

Fundamental Drivers

The 15.1% change in HQY stock from 10/31/2025 to 11/4/2026 was primarily driven by a 51.1% change in the company's Net Income Margin (%).
(LTM values as of)1031202511042026Change
Stock Price ($)94.58108.8415.1%
Change Contribution By: 
Total Revenues ($ Mil)1,2691,3627.3%
Net Income Margin (%)11.5%17.4%51.1%
P/E Multiple56.138.4-31.6%
Shares Outstanding (Mil)87833.8%
Cumulative Contribution15.1%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 11/4/2026
ReturnCorrelation
HQY15.1% 
Market (SPY)13.4%16.8%
Sector (XLV)33.2%31.7%

Fundamental Drivers

The 51.8% change in HQY stock from 10/31/2023 to 11/4/2026 was primarily driven by a 1169.7% change in the company's Net Income Margin (%).
(LTM values as of)1031202311042026Change
Stock Price ($)71.68108.8451.8%
Change Contribution By: 
Total Revenues ($ Mil)9381,36245.2%
Net Income Margin (%)1.4%17.4%1169.7%
P/E Multiple478.138.4-92.0%
Shares Outstanding (Mil)86832.6%
Cumulative Contribution51.8%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2023 to 11/4/2026
ReturnCorrelation
HQY51.8% 
Market (SPY)89.7%33.5%
Sector (XLV)59.5%25.0%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
HQY Return-37%39%8%45%-5%19%56%
Peers Return13%-1%15%18%-20%17%44%
S&P 500 Return27%-19%24%23%16%11%102%

Monthly Win Rates [3]
HQY Win Rate42%58%42%67%42%55% 
Peers Win Rate53%48%57%65%45%56% 
S&P 500 Win Rate75%42%67%75%67%36% 

Max Drawdowns [4]
HQY Max Drawdown-57%-27%-24%-22%-33%-26% 
Peers Max Drawdown-21%-23%-17%-16%-39%-27% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: WEX, VOYA, ADP, PAYX, FISV. See HQY Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 11/4/2026 (YTD)

How Low Can It Go

EventHQYS&P 500
2024 Yen Carry Trade Unwind
  % Loss-14.0%-7.8%
  % Gain to Breakeven16.3%8.5%
  Time to Breakeven25 days18 days
2023 SVB Regional Banking Crisis
  % Loss-19.2%-6.7%
  % Gain to Breakeven23.7%7.1%
  Time to Breakeven34 days31 days
2020 COVID-19 Crash
  % Loss-53.2%-33.7%
  % Gain to Breakeven113.7%50.9%
  Time to Breakeven314 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-43.4%-19.2%
  % Gain to Breakeven76.8%23.8%
  Time to Breakeven2129 days105 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-18.8%-3.7%
  % Gain to Breakeven23.1%3.9%
  Time to Breakeven6 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-52.9%-12.2%
  % Gain to Breakeven112.4%13.9%
  Time to Breakeven214 days62 days

Compare to WEX, VOYA, ADP, PAYX, FISV

In The Past

HealthEquity's stock fell -14.0% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 16.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventHQYS&P 500
2020 COVID-19 Crash
  % Loss-53.2%-33.7%
  % Gain to Breakeven113.7%50.9%
  Time to Breakeven314 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-43.4%-19.2%
  % Gain to Breakeven76.8%23.8%
  Time to Breakeven2129 days105 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-52.9%-12.2%
  % Gain to Breakeven112.4%13.9%
  Time to Breakeven214 days62 days

Compare to WEX, VOYA, ADP, PAYX, FISV

In The Past

HealthEquity's stock fell -14.0% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 16.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About HealthEquity (HQY)

HealthEquity, Inc. provides technology-enabled service platforms designed to empower individuals and employers in the United States to manage their health savings and spending effectively. The company's core mission is to help consumers make informed financial decisions related to healthcare, including paying bills, comparing treatment options and prices, and growing their health savings through investment choices.

The company's primary products and services center around health savings accounts (HSAs), which often include a mutual fund investment platform and online automated investment advisory services. Beyond HSAs, HealthEquity also administers other pre-tax benefit accounts such as flexible spending accounts (FSAs) and health reimbursement arrangements (HRAs). Additionally, it offers Consolidated Omnibus Budget Reconciliation Act (COBRA) continuation services and manages pre-tax commuter benefit programs.

HealthEquity serves two main customer segments: individual consumers and employers. The company utilizes a multi-pronged approach to reach its market, including a direct sales force, collaborations with benefits brokers and advisors, and strategic partnerships with health plans, benefits administrators, and retirement plan record-keepers across the United States.

AI Analysis | Feedback

```html
  • Mint.com for health expenses and savings.
  • Fidelity for your health savings and investment accounts.
  • ADP for managing health and commuter benefits.
```

AI Analysis | Feedback

  • Technology-enabled Health Finance Platform: Cloud-based platforms empowering individuals to manage health savings, spending, and investment decisions, offering tools for comparison, personalized information, and wellness incentives.
  • Health Savings Accounts (HSAs): Administration of tax-advantaged savings accounts used to pay for qualified medical expenses.
  • Flexible Spending Accounts (FSAs): Administration of employer-sponsored plans allowing pre-tax contributions for healthcare or dependent care expenses.
  • Health Reimbursement Arrangements (HRAs): Administration of employer-funded plans that reimburse employees for out-of-pocket medical expenses.
  • Mutual Fund Investment Platform: A platform providing options for investing funds held in health savings accounts into various mutual funds.
  • Automated Investment Advisory Services (Advisor): An online tool offering automated investment advice specifically for health savings accounts.
  • COBRA Continuation Services: Administration of services enabling individuals to continue health coverage after certain qualifying events.
  • Pre-tax Commuter Benefit Programs: Administration of programs allowing employees to use pre-tax earnings for qualified commuting expenses.

AI Analysis | Feedback

Major Customers of HealthEquity (HQY)

HealthEquity (HQY) sells its technology-enabled services platforms primarily to other companies, which then often make these services available to individuals (their employees or members). The provided company description does not list specific names of customer companies.

Based on the description, HealthEquity's major customers and partners fall into the following categories:

  • Employers: HealthEquity provides platforms directly to employers for their employees to manage health savings and spending.
  • Health Plans: The company works with a network of health plans, which likely integrate or offer HealthEquity's services to their members.
  • Benefits Administrators: HealthEquity serves benefits administrators, who manage various employee benefits programs for other companies.
  • Benefits Brokers and Consultants: These intermediaries recommend and facilitate the adoption of HealthEquity's solutions to employers and other organizations.
  • Retirement Plan Record-keepers: The company partners with retirement plan record-keepers, integrating its health savings and investment options into broader financial wellness offerings.

AI Analysis | Feedback

  • Axos Bank (AX)

AI Analysis | Feedback

Scott Cutler, President / CEO

Scott Cutler became President and CEO of HealthEquity in January 2025. He brings a strong background in leveraging technology to empower consumers and transforming service experiences. Before joining HealthEquity, he served as CEO of StockX, a leading consumer e-commerce marketplace, and held key leadership roles at eBay, including Senior Vice President of the Americas. He also served as President of StubHub and Executive Vice President at the New York Stock Exchange. Earlier in his career, he worked as a technology investment banker and a corporate securities lawyer.

James Lucania, EVP / Chief Financial Officer

James Lucania was appointed Executive Vice President and Chief Financial Officer of HealthEquity, with his term commencing in September 2023. He has over two decades of experience in finance leadership. Prior to HealthEquity, he served as CFO at Ascensus starting in 2016 and as CFO of Checkpoint Systems, where he successfully executed a strategic sale. His background also includes roles at Miller Buckfire & Co., focusing on corporate restructuring and M&A transactions, and leadership positions at Levine Leichtman Capital Partners, indicating experience with private equity firms.

Stephen D. Neeleman, MD, Founder / Vice Chair

Dr. Stephen D. Neeleman founded HealthEquity in 2002 with a vision to connect health and wealth for Americans and re-introduce consumerism to healthcare. He has served as Vice Chairman since February 2014, and previously as President and Chief Executive Officer from November 2002 through January 2014. He is also the co-author of "The Complete HSA Guidebook—How to Make Health Savings Accounts Work for You."

Eli Rosner, EVP / Chief Technology Officer

Eli Rosner joined HealthEquity in 2022 as EVP and Chief Technology Officer. Before this, he was the Chief Product and Technology Officer at Finastra, a global provider of financial services software. He also served as CTO and Head of Product Management, where he was instrumental in transforming a hardware and services company into a global leader in platform, data, and solutions for various sectors including financial services and retail.

Del Ladd, EVP / General Counsel

Del Ladd serves as the Executive Vice President, General Counsel, and Secretary of HealthEquity, a position he has held since joining the company in 2016. He leads the Legal Department and possesses substantial experience in corporate governance, securities, and mergers and acquisitions. Prior to his time at HealthEquity, Mr. Ladd worked for Willkie Farr & Gallagher LLP in New York.

AI Analysis | Feedback

HealthEquity (HQY) faces several key risks to its business operations and financial performance:

  1. Interest Rate Sensitivity: A significant portion of HealthEquity's custodial revenue is derived from the interest earned on cash assets held within Health Savings Accounts (HSAs). Consequently, a decline in interest rates could lead to a reduction in this crucial revenue stream, impacting the company's profitability.
  2. Competitive Landscape: HealthEquity operates in a highly competitive market for health savings and consumer-directed benefits administration. The company faces stiff competition from diversified financial institutions, such as Fidelity Investments and Optum (part of UnitedHealth Group), which can leverage their extensive client bases and offer bundled services, potentially eroding HealthEquity's market share and pricing power.
  3. Regulatory and Legislative Changes: HealthEquity's business model is largely dependent on the existing regulatory and legislative framework governing tax-advantaged HSAs and other consumer-directed benefits. Any adverse changes to these policies, including shifts in eligibility criteria, contribution limits, or the overall healthcare regulatory environment, could significantly impact the demand for its services and its financial results.

AI Analysis | Feedback

The rapid advancement and integration of artificial intelligence (AI) and large language models (LLMs) into personal finance and healthcare management platforms pose an emerging threat. These technologies could enable new entrants, existing financial institutions, or major tech companies to offer highly personalized, automated, and proactive solutions for health saving and spending decisions, treatment cost comparisons, and HSA investment optimization. Such advanced AI-driven tools, potentially embedded directly into broader financial wellness platforms, electronic health records, or consumer-facing apps, could diminish the unique value proposition and necessity of HealthEquity's dedicated cloud-based platforms and advisory services by providing a more integrated and autonomous user experience.

AI Analysis | Feedback

HealthEquity, Inc. (HQY) addresses several significant markets within the United States for its main products and services:

  • Health Savings Accounts (HSAs): The U.S. HSA market is substantial and growing. As of midyear 2025, HSA assets reached approximately $159 billion across 40 million accounts. This market is projected to exceed 47 million accounts and hold over $208 billion in total assets by the end of 2027. Furthermore, new tax legislation enacted in July 2025 is anticipated to broaden eligibility for HSAs, making them accessible to an additional 10 million Americans starting in 2026.
  • Flexible Spending Accounts (FSAs): The Flexible Spending Account solution market, globally, was estimated at $15 billion in 2025 and is projected to grow to approximately $28 billion by 2033, with a Compound Annual Growth Rate (CAGR) of 8%. The United States is expected to dominate this market. Annual spending tied to FSAs in American households is estimated to be $36 billion. In 2024, a survey indicated that 72% of state and local government workers and 47% of private-sector workers in the U.S. had access to a health care flexible spending account.
  • Health Reimbursement Arrangements (HRAs) and Consolidated Omnibus Budget Reconciliation Act (COBRA) Continuation Services: These services fall under the broader Benefits Administration Service Market. The global Benefits Administration Service Market is estimated to be valued at US$ 934.7 million in 2025 and is expected to reach US$ 1,697.7 million by 2032, growing at a CAGR of 8.9% from 2025 to 2032. North America is estimated to lead this market, holding a 41.2% share in 2025. The core benefits administration segment, which includes COBRA administration and FSA/HSA account management, is expected to be a leading segment within this market, holding a 39.6% share in 2025.
  • Pre-Tax Commuter Benefit Programs: In the U.S., subsidized commuting was available to 10% of all private industry workers in 2024. For 2026, the IRS permits employees to exclude up to $340 per month for public transportation and $340 per month for qualified parking separately as pre-tax commuter benefits. Employers offering these programs can save approximately $532 in FICA taxes per employee per year, while employees can save an average of $800 per year.

AI Analysis | Feedback

HealthEquity (HQY) is expected to drive future revenue growth over the next 2-3 years through several key initiatives and market trends:

  1. Continued Growth in Health Savings Accounts (HSAs) and Assets: HealthEquity, as the nation's largest HSA custodian, is poised to benefit from the increasing demand for tax-advantaged healthcare spending and savings solutions. The company has reported solid year-over-year growth in HSA accounts and assets, with projections indicating continued expansion in this core business. This growth underpins a scaling, diversified fee and yield model.
  2. Optimizing Custodial Revenue and Yield on HSA Cash: A significant portion of HealthEquity's revenue is derived from custodial revenue and the yield generated on Health Savings Account (HSA) cash. The company's ability to maintain or improve its average annualized yield on HSA cash, partly through its Enhanced Rates offering and strategic cash placements, will be a key driver of revenue growth.
  3. Investments in Technology and Digital Engagement: HealthEquity is focused on modernizing its business, enhancing security, and accelerating the digital experience to drive engagement with its platforms. Initiatives include a new direct HSA enrollment platform and advanced AI-powered solutions (such as agentic AI, Expedited Claims AI, and HSAnswers), which are expected to increase trust, engagement, and product adoption among consumers and partners.
  4. Expansion of Product and Service Offerings: The company is expanding its HealthEquity marketplace platform to provide greater access to affordable healthcare solutions. This includes the introduction of programs supporting weight loss through GLP-1s, demonstrating a strategy to diversify offerings beyond traditional HSAs and cater to evolving healthcare needs.
  5. Deepening Relationships with Employers and Members: HealthEquity aims to further strengthen its relationships with employers and members. This involves working with employers and partners on plan design to support HSA adoption and securing new employer clients, which is crucial for driving ongoing product adoption and expanding its customer base.

AI Analysis | Feedback

Capital Allocation Decisions of HealthEquity (HQY)

Share Repurchases

  • HealthEquity repurchased 1.0 million shares for $93.7 million during the third quarter ended October 31, 2025, with $258.8 million remaining authorized for future repurchases.
  • The company repurchased 0.7 million shares for $66.0 million during the second quarter ended July 31, 2025.
  • Under a buyback program announced on September 3, 2024, HealthEquity completed the repurchase of 3,294,219 shares for US$300 million by September 30, 2025.

Share Issuance

  • HealthEquity's shares outstanding increased by 2.15% to 0.089 billion in 2025 from 2024.
  • Shares outstanding increased by 2.98% to 0.087 billion in 2024 from 2023.
  • The company's shares outstanding saw a 1.57% increase in 2023 from 2022.

Outbound Investments

  • In November 2021, HealthEquity acquired Further, an HSA and consumer-directed benefit administration services provider, for $455 million, with a potential additional $45 million.
  • In March 2022, HealthEquity acquired the Health Savings Administrators, L.L.C. HSA portfolio for $60 million in cash.
  • During fiscal year 2025 (ending January 31, 2025), HealthEquity acquired the BenefitWallet HSA portfolio for $425.0 million.

Capital Expenditures

  • HealthEquity's annual capital expenditures were $505.454 million in 2025, $46.074 million in 2024, and $119.127 million in 2023.
  • The trailing twelve months (TTM) annual capital expenditures for HealthEquity were $52.261 million as of March 9, 2026.
  • Quarterly capital expenditures for the periods ending October 31, 2025, July 31, 2025, and April 30, 2025, were $11.381 million, $11.18 million, and $16.143 million, respectively.

Better Bets vs. HealthEquity (HQY)

Peer Outperformance in Managed Health Care

HQY has outperformed 86% of its 7 Managed Health Care peers over 5Y. Managed Health Care ranks 3rd of 10 industries in Health Care by median 5Y return. That makes it one of the strongest corners of the sector.
Share of Managed Health Care constituents that HQY has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.
1Y
0%
of 7 industry peers · 14.5% return
3Y
71%
of 7 industry peers · 69.7% return
5Y
86%
of 7 industry peers · 59.1% return
No Managed Health Care peer with a comparable growth profile has beaten HQY by more than 20pp over 5Y.
Median price return by industry across the Health Care sector, ranked by 5Y. Managed Health Care is HQY's own industry. Use this to see which corners of the sector have carried the returns.
Industry Names 1Y med3Y med5Y med Top 3 by 5Y
Health Care Distributors 6 13.4%63.7%103.3% CAH 490% · MCK 391% · COR 194%
Health Care Services 20 44.0%33.3%11.6% HIMS 220% · RDNT 148% · DGX 96%
Managed Health Care ← 8 44.6%5.6%0.6% OSCR 107% · HQY 59% · ELV 11%
Health Care Facilities 25 16.9%18.4%-3.0% THC 302% · NHC 241% · EHC 202%
Health Care Equipment 50 14.4%18.7%-15.0% UFPT 408% · GKOS 348% · PLSE 147%
Pharmaceuticals 60 -5.1%8.2%-35.2% LQDA 999% · KNSA 546% · LLY 448%
Health Care Supplies 11 34.9%23.0%-36.1% LNTH 267% · HAE 76% · MMSI 33%
Life Sciences Tools & Services 108 -6.2%-10.3%-74.1% AXGN 288% · NTRA 253% · MEDP 189%
Biotechnology 364 -21.1%-31.5%-81.7% ELVN 1112% · TRVI 1046% · DNTH 930%
Health Care Technology 21 -23.4%-56.5%-82.3% VEEV -3% · DOCS -52%
Median of constituents with a full price history over each window. Top names are limited to companies above $2B market cap.

Latest Trefis Analyses

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

HQYWEXVOYAADPPAYXFISVMedian
NameHealthEq.WEX Voya Fin.Automati.Paychex Fiserv  
Mkt Price108.30180.12104.59303.48118.8061.90113.55
Mkt Cap9.06.19.5120.342.332.921.2
Rev LTM1,3622,8808,01822,2636,60220,7997,310
Op Inc LTM356766-5,9092,5883,9882,588
FCF LTM437-3501,1924,7562,0173,1581,604
FCF 3Y Avg1842471,2894,3481,8234,0861,556
CFO LTM490-1251,1925,4502,2525,0381,722
CFO 3Y Avg3884261,2894,9542,0255,7941,657

Growth & Margins

HQYWEXVOYAADPPAYXFISVMedian
NameHealthEq.WEX Voya Fin.Automati.Paychex Fiserv  
Rev Chg LTM7.3%9.8%3.3%6.5%14.0%-1.7%6.9%
Rev Chg 3Y Avg13.3%4.9%7.1%6.7%9.2%3.5%6.9%
Rev Chg Q7.6%12.8%-1.3%6.1%5.9%-1.3%6.0%
QoQ Delta Rev Chg LTM1.9%3.2%-0.3%1.4%1.4%-0.3%1.4%
Op Inc Chg LTM30.1%17.0%-8.0%17.5%-34.4%17.0%
Op Inc Chg 3Y Avg65.5%6.3%-8.7%7.9%-0.8%7.9%
Op Mgn LTM26.1%26.6%-26.5%39.2%19.2%26.5%
Op Mgn 3Y Avg21.3%25.8%-26.3%39.5%25.3%25.8%
QoQ Delta Op Mgn LTM0.2%1.1%-0.2%0.6%-2.2%0.2%
CFO/Rev LTM36.0%-4.3%14.9%24.5%34.1%24.2%24.4%
CFO/Rev 3Y Avg31.0%16.3%16.6%23.7%34.3%28.0%25.9%
FCF/Rev LTM32.1%-12.1%14.9%21.4%30.5%15.2%18.3%
FCF/Rev 3Y Avg12.9%9.8%16.6%20.8%30.9%19.8%18.2%

Valuation

HQYWEXVOYAADPPAYXFISVMedian
NameHealthEq.WEX Voya Fin.Automati.Paychex Fiserv  
Mkt Cap9.06.19.5120.342.332.921.2
P/S6.62.11.25.46.41.63.8
P/Op Inc25.48.0-20.416.38.316.3
P/EBIT25.07.99.619.016.0-16.412.8
P/E38.215.115.626.623.4-8.419.5
P/CFO18.4-48.98.022.118.86.513.2
Total Yield2.6%6.6%8.3%6.0%8.1%-11.9%6.3%
Dividend Yield0.0%0.0%1.9%2.2%3.8%0.0%0.9%
FCF Yield 3Y Avg2.2%3.7%17.6%3.9%4.3%8.0%4.1%
D/E0.10.90.30.00.10.80.2
Net D/E0.10.0-2.60.00.10.80.0

Returns

HQYWEXVOYAADPPAYXFISVMedian
NameHealthEq.WEX Voya Fin.Automati.Paychex Fiserv  
1M Rtn18.3%4.4%6.6%16.6%20.3%34.2%17.5%
3M Rtn3.7%-4.4%5.0%13.1%1.5%14.4%4.3%
6M Rtn30.1%25.1%31.4%48.5%34.4%10.3%30.7%
12M Rtn14.0%21.7%45.4%20.5%8.8%-4.0%17.2%
3Y Rtn68.8%2.7%60.3%48.7%20.3%-48.2%34.5%
1M Excs Rtn22.1%8.2%10.1%18.9%22.0%39.3%20.4%
3M Excs Rtn6.5%-3.1%5.4%13.5%1.7%16.2%5.9%
6M Excs Rtn27.3%22.3%28.6%45.8%31.6%7.6%28.0%
12M Excs Rtn3.8%9.1%36.0%11.0%-1.6%-15.4%6.4%
3Y Excs Rtn-31.9%-71.5%-11.5%-30.7%-61.5%-126.6%-46.7%

Financials

Segment Financials

Revenue by Segment
$ Mil20262025202420232022
Administration services in connection with health savings accounts (HSAs) and other consumer1,3131,2001,000862757
Total1,3131,2001,000862757


Price Behavior

Price Behavior
Market Price$108.84 
Market Cap ($ Bil)9.1 
First Trading Date07/31/2014 
Distance from 52W High0.0% 
   50 Days200 Days
DMA Price$95.34$89.30
DMA Trenddownindeterminate
Distance from DMA14.2%21.9%
 3M1YR
Volatility35.0%35.6%
Downside Capture14.9950.52
Upside Capture7.7053.15
Correlation (S&P 500)-10.5%15.7%
HQY Betas & Captures as of 10/31/2026

 1M2M3M6M1Y3Y
Beta-0.31-0.08-0.02-0.270.420.78
Up Beta-4.14-2.03-0.14-0.430.650.88
Down Beta-0.98-1.49-1.08-0.880.040.98
Up Capture153%86%29%21%39%29%
Bmk +ve Days12182862130427
Stock +ve Days14233468136394
Down Capture-90%32%23%-42%52%82%
Bmk -ve Days10253664121325
Stock -ve Days8203058113351

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HQY
HQY14.9%35.6%0.44-
Sector ETF (XLV)33.1%16.7%1.5331.7%
Equity (SPY)13.2%12.9%0.6816.8%
Gold (GLD)1.0%28.8%0.03-5.8%
Commodities (DBC)35.9%21.2%1.34-17.8%
Real Estate (VNQ)14.3%14.1%0.7022.3%
Bitcoin (BTCUSD)-28.2%43.4%-0.655.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HQY
HQY10.6%39.8%0.36-
Sector ETF (XLV)9.3%15.3%0.4021.5%
Equity (SPY)12.5%17.2%0.5527.3%
Gold (GLD)17.3%19.1%0.73-11.2%
Commodities (DBC)8.0%19.6%0.293.9%
Real Estate (VNQ)1.8%18.9%-0.0113.2%
Bitcoin (BTCUSD)5.5%51.5%0.2910.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HQY
HQY12.2%44.6%0.42-
Sector ETF (XLV)12.5%16.8%0.6137.8%
Equity (SPY)15.4%18.0%0.7342.8%
Gold (GLD)11.9%16.5%0.59-9.9%
Commodities (DBC)7.4%18.1%0.3314.5%
Real Estate (VNQ)5.7%20.7%0.2330.2%
Bitcoin (BTCUSD)61.0%66.2%1.018.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date10152026
Short Interest: Shares Quantity5.9 Mil
Short Interest: % Change Since 9302026-0.8%
Average Daily Volume0.8 Mil
Days-to-Cover Short Interest7.8 days
Basic Shares Quantity83.4 Mil
Short % of Basic Shares7.1%

Earnings Returns History

Updated 10/9/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/27/2026-10.6%-5.6%-15.5%
5/28/2026-2.8%-5.0%-3.0%
3/17/20260.2%3.4%6.5%
12/3/2025-3.0%-3.0%-3.2%
9/2/20257.5%4.7%2.1%
6/3/20259.0%3.3%-1.9%
3/18/2025-17.1%-11.3%-18.9%
12/9/2024-5.6%-7.8%-0.7%
...
SUMMARY STATS   
# Positive131011
# Negative111413
Median Positive3.8%5.1%6.5%
Median Negative-3.0%-5.3%-3.2%
Max Positive11.6%14.3%18.8%
Max Negative-24.6%-27.4%-18.9%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/27/2026-10.6%-5.6%-15.5%
5/28/2026-2.8%-5.0%-3.0%
3/17/20260.2%3.4%6.5%
12/3/2025-3.0%-3.0%-3.2%
9/2/20257.5%4.7%2.1%
6/3/20259.0%3.3%-1.9%
3/18/2025-17.1%-11.3%-18.9%
12/9/2024-5.6%-7.8%-0.7%
9/3/20245.1%-5.0%0.6%
6/3/20242.7%7.0%2.9%
3/19/2024-2.6%-4.8%-4.4%
12/5/20230.4%1.3%-1.6%
9/5/20233.8%5.6%7.9%
6/5/202311.6%8.9%12.0%
3/21/2023-1.9%-1.4%-2.1%
12/6/20220.7%-7.9%-7.9%
9/6/20221.0%10.3%7.6%
6/6/20224.7%3.5%0.1%
3/22/20221.1%14.3%18.8%
12/6/2021-24.6%-27.4%-17.9%
9/8/20214.4%-2.9%2.6%
6/7/2021-1.1%-6.5%-3.0%
3/15/2021-7.1%-11.6%-12.9%
12/7/2020-1.1%-4.0%13.4%
SUMMARY STATS   
# Positive131011
# Negative111413
Median Positive3.8%5.1%6.5%
Median Negative-3.0%-5.3%-3.2%
Max Positive11.6%14.3%18.8%
Max Negative-24.6%-27.4%-18.9%

SEC Filings

Expand for More
Report DateFiling DateFiling
07/31/202608/27/202610-Q
04/30/202605/28/202610-Q
01/31/202603/17/202610-K
10/31/202512/03/202510-Q
07/31/202509/02/202510-Q
04/30/202506/03/202510-Q
01/31/202503/18/202510-K
10/31/202412/09/202410-Q
07/31/202409/03/202410-Q
04/30/202406/03/202410-Q
01/31/202403/22/202410-K
10/31/202312/05/202310-Q
07/31/202309/05/202310-Q
04/30/202306/07/202310-Q
01/31/202303/30/202310-K
10/31/202212/08/202210-Q
Collapse to Preview
Report DateFiling DateFiling
07/31/202608/27/202610-Q
04/30/202605/28/202610-Q
01/31/202603/17/202610-K
10/31/202512/03/202510-Q
07/31/202509/02/202510-Q
04/30/202506/03/202510-Q
01/31/202503/18/202510-K
10/31/202412/09/202410-Q
07/31/202409/03/202410-Q
04/30/202406/03/202410-Q
01/31/202403/22/202410-K
10/31/202312/05/202310-Q
07/31/202309/05/202310-Q
04/30/202306/07/202310-Q
01/31/202303/30/202310-K
10/31/202212/08/202210-Q
07/31/202209/08/202210-Q
04/30/202206/08/202210-Q
01/31/202203/31/202210-K
10/31/202112/09/202110-Q
07/31/202109/09/202110-Q
04/30/202106/08/202110-Q
01/31/202103/31/202110-K
10/31/202012/09/202010-Q
07/31/202009/09/202010-Q
04/30/202006/04/202010-Q
01/31/202003/31/202010-K
10/31/201912/05/201910-Q

Recent Forward Guidance

Updated 10/4/2026

Latest: Q2 2026 Earnings Reported 8/27/2026

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2027 RevenueReported1.41 Bil1.42 Bil1.42 Bil0.1% RaisedGuidance: 1.42 Bil for 2027
2027 Adjusted EBITDAReported628.00 Mil632.00 Mil636.00 Mil0.5% RaisedGuidance: 629.00 Mil for 2027
2027 Net IncomeReported242.00 Mil245.00 Mil248.00 Mil0 AffirmedGuidance: 245.00 Mil for 2027
2027 Non-GAAP Net IncomeReported392.00 Mil395.00 Mil398.00 Mil0 AffirmedGuidance: 395.00 Mil for 2027


Prior: Q1 2026 Earnings Reported 5/28/2026

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2027 RevenueReported1.41 Bil1.42 Bil1.42 Bil0.4% RaisedGuidance: 1.41 Bil for 2027
2027 Adjusted EBITDAReported625.00 Mil629.00 Mil633.00 Mil1.0% RaisedGuidance: 623.00 Mil for 2027
2027 Net IncomeReported242.00 Mil245.00 Mil248.00 Mil1.0% RaisedGuidance: 242.50 Mil for 2027
2027 Non-GAAP Net IncomeReported392.00 Mil395.00 Mil398.00 Mil-0.3% LoweredGuidance: 396.00 Mil for 2027
2027 EPSReported2.882.922.953.6% RaisedGuidance: 2.82 for 2027
2027 Non-GAAP EPSReported4.664.74.732.0% RaisedGuidance: 4.61 for 2027

Q4 2026 Earnings Reported 3/17/2026

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2027 RevenueReported1.41 Bil1.41 Bil1.42 Bil7.9% Higher NewGuidance: 1.31 Bil for 2026
2027 Adjusted EBITDAReported618.00 Mil623.00 Mil628.00 Mil11.2% Higher NewGuidance: 560.00 Mil for 2026
2027 Net IncomeReported239.00 Mil242.50 Mil246.00 Mil20.6% Higher NewGuidance: 201.00 Mil for 2026
2027 Non-GAAP Net IncomeReported392.00 Mil396.00 Mil400.00 Mil14.9% Higher NewGuidance: 344.50 Mil for 2026
2027 EPSReported2.782.822.8523.2% Higher NewGuidance: 2.29 for 2026
2027 Non-GAAP EPSReported4.564.614.6517.8% Higher NewGuidance: 3.91 for 2026

Q3 2026 Earnings Reported 12/3/2025

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2026 RevenueReported1.30 Bil1.31 Bil1.31 Bil0.5% RaisedGuidance: 1.30 Bil for 2026
2026 Adjusted EBITDAReported555.00 Mil560.00 Mil565.00 Mil1.8% RaisedGuidance: 550.00 Mil for 2026
2026 Net IncomeReported197.00 Mil201.00 Mil205.00 Mil4.4% RaisedGuidance: 192.50 Mil for 2026
2026 Non-GAAP Net IncomeReported341.00 Mil344.50 Mil348.00 Mil2.4% RaisedGuidance: 336.50 Mil for 2026
2026 EPSReported2.242.292.334.1% RaisedGuidance: 2.2 for 2026
2026 Non-GAAP EPSReported3.873.913.952.2% RaisedGuidance: 3.83 for 2026

Insider Activity

Updated 10/19/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Rajasekar, SunilEVP Chief Prod & Strat OfficerDirectBuy1019202690.331089,7564,824,074Form
2Rajasekar, SunilEVP Chief Prod & Strat OfficerDirectSell10192026105.6010811,4055,628,163Form
3Rajasekar, SunilEVP Chief Prod & Strat OfficerDirectBuy1019202695.06232,1865,076,679Form
4Rajasekar, SunilEVP Chief Prod & Strat OfficerDirectSell1019202682.81231,9054,420,563Form
5Dillon, Adrian TDirectSell8272026104.617,632798,3736,527,054Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Rajasekar, SunilEVP Chief Prod & Strat OfficerDirectBuy1019202690.331089,7564,824,074Form
2Rajasekar, SunilEVP Chief Prod & Strat OfficerDirectSell10192026105.6010811,4055,628,163Form
3Rajasekar, SunilEVP Chief Prod & Strat OfficerDirectBuy1019202695.06232,1865,076,679Form
4Rajasekar, SunilEVP Chief Prod & Strat OfficerDirectSell1019202682.81231,9054,420,563Form
5Dillon, Adrian TDirectSell8272026104.617,632798,3736,527,054Form
6Fiore, Michael HenryEVP, CHIEF COMMERCIAL OFFICERDirectSell714202695.002,354223,6304,963,180Form
7Fiore, Michael HenryEVP, CHIEF COMMERCIAL OFFICERDirectSell707202695.002,470234,6505,381,085Form
8Fiore, Michael HenryEVP, CHIEF COMMERCIAL OFFICERDirectSell602202695.003,142298,4905,615,735Form
9Wellborn, Gayle FurgursonDirectSell601202690.002,439219,5101,775,970Form
10Ladd, DelanoEVP, General CounselDirectSell601202690.007,500675,0008,202,690Form
11Ladd, DelanoEVP, General CounselDirectSell1223202594.721,500142,0807,007,291Form
12Rosner, ElimelechEVP, CHIEF TECHNOLOGY OFFICERDirectSell1219202595.4510,9591,046,0904,366,298Form
13Wellborn, Gayle FurgursonDirectSell1216202598.034,339425,3311,934,329Form
14Ladd, DelanoEVP, General CounselDirectSell11242025104.561,500156,8407,892,084Form
15Ladd, DelanoEVP, General CounselDirectSell1022202592.071,500138,1057,087,457Form
16Fiore, Michael HenryEVP, CHIEF COMMERCIAL OFFICERDirectSell1008202588.211,781157,1024,392,417Form

Investor Activity (13F)

Updated Nov 5, 2026
13F holdings as of Mar 31, 2026 (Q1 2026)

Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Cadian Capital Management, LP$69.6 Mil8.5%23ADD +46.9%13F
Atalan Capital Partners, LP$73.8 Mil6.8%10Hold13F
Greenhouse Funds LLLP$105.1 Mil5.0%28ADD +16.5%13F
Park West Asset Management LLC$52.1 Mil4.6%48New13F
12th Street Asset Management Company, LLC$21.0 Mil3.4%32Hold13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Park West Asset Management LLC$52.1 Mil4.6%48New13F
Cadian Capital Management, LP$69.6 Mil8.5%23ADD +46.9%13F
Greenhouse Funds LLLP$105.1 Mil5.0%28ADD +16.5%13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Boone Capital Management LLC$19.5 Mil6.1%15Exited13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Greenhouse Funds LLLP$105.1 Mil5.0%28ADD +16.5%13F
Atalan Capital Partners, LP$73.8 Mil6.8%10Hold13F
Cadian Capital Management, LP$69.6 Mil8.5%23ADD +46.9%13F
Park West Asset Management LLC$52.1 Mil4.6%48New13F
12th Street Asset Management Company, LLC$21.0 Mil3.4%32Hold13F
Core Cache Last Updated: 11/4/2026